In this issue:
Intracoronary infusion of cardiac stem cells
Enoxaparin improves PCI outcomes
Clopidogrel discontinuation associated with adverse outcomes
Dose-dependent increase in bleeding with dabigatran
Obesity paradox does not persist long term
PCI benefits decline with transfer delays
Fewer coronary risk factors associated with increased mortality
Myeloperoxidase has no diagnostic value in ACS
Longer testing with troponin I assay unnecessary
Please login below to download this issue (PDF)